Functional Fluidics

Executive Summary

Functional Fluidics is a CLIA-certified diagnostic laboratory and contract research organization (CRO) based in Detroit, Michigan, founded in 2013. The company specializes in red blood cell (RBC) function analysis, offering proprietary biomarker assays and testing services primarily for sickle cell disease (SCD) drug development, clinical trials, and patient care. Its mission is to establish the gold standard for objectively measuring and monitoring RBC health. By providing high-complexity diagnostic testing, Functional Fluidics supports both academic and pharmaceutical partners in evaluating novel therapies, with a focus on SCD where there remains a significant unmet need for sensitive, quantitative biomarkers to assess treatment efficacy. The company operates in the diagnostic and CRO space, positioning itself as a key enabler for drug development in hematologic disorders. Despite being at a pre-clinical stage, its CLIA certification and existing assay menu suggest readiness to support clinical trials and generate scientific data that can accelerate therapeutic advancements.

Upcoming Catalysts (preview)

• Q3 2026Partnership with a major pharmaceutical company for SCD clinical trial support40% success
• Q4 2026Launch of a new proprietary biomarker assay for RBC function50% success
• Q4 2026Publication of validation data in a peer-reviewed journal enhancing credibility60% success